Cargando…
Balancing risk and benefit during coronavirus
Autor principal: | Sehn, Laurie H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243145/ https://www.ncbi.nlm.nih.gov/pubmed/32275744 http://dx.doi.org/10.1182/blood.2020006279 |
Ejemplares similares
-
Balancing risks and benefits of artificial intelligence in the health sector
por: Goodman, Kenneth, et al.
Publicado: (2020) -
Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit
por: Ewer, Michael S, et al.
Publicado: (2016) -
Neurosurgical innovation: balancing the risks and benefits of technical novelty
por: Cohen-Gadol, Aaron A.
Publicado: (2019) -
Benefit-risk balance of COVID drugs. New prospects
por: Cracowski, Jean-Luc, et al.
Publicado: (2022) -
Balancing the risks and benefits of biologic drugs in rheumatic
disease: the case for romosozumab?
por: Reid, David M.
Publicado: (2020)